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INTRODUCTION
Cardiovascular magnetic resonance imaging (CMR) is 
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Objective: To compare native and post-contrast T1 mapping with late gadolinium enhancement (LGE) imaging for detecting 
and measuring the microvascular obstruction (MVO) area in reperfused acute myocardial infarction (MI).
Materials and Methods: This study included 20 patients with acute MI who had undergone 1.5T cardiovascular magnetic 
resonance imaging (CMR) after reperfusion therapy. CMR included cine imaging, LGE, and T1 mapping (modified look-locker 
inversion recovery). MI size was calculated from LGE by full-width at half-maximum technique. MVO was defined as an area 
with low signal intensity (LGE) or as a region of visually distinguishable T1 values (T1 maps) within infarcted myocardium. 
Regional T1 values were measured in MVO, infarcted, and remote myocardium on T1 maps. MVO area was measured on and 
compared among LGE, native, and post-contrast T1 maps.
Results: The mean MI size was 27.1 ± 9.7% of the left ventricular mass. Of the 20 identified MVOs, 18 (90%) were detected 
on native T1 maps, while 10 (50%) were recognized on post-contrast T1 maps. The mean native T1 values of MVO, infarcted, 
and remote myocardium were 1013.5 ± 58.5, 1240.9 ± 55.8 (p < 0.001), and 1062.2 ± 55.8 ms (p = 0.169), respectively, while 
the mean post-contrast T1 values were 466.7 ± 26.8, 399.1 ± 21.3, and 585.2 ± 21.3 ms, respectively (p < 0.001). The mean 
MVO areas on LGE, native, and post-contrast T1 maps were 134.1 ± 81.2, 133.7 ± 80.4, and 117.1 ± 53.3 mm2, respectively. 
The median (interquartile range) MVO areas on LGE, native, and post-contrast T1 maps were 128.0 (58.1–215.4), 110.5 
(67.7–227.9), and 143.0 (76.7–155.3) mm2, respectively (p = 0.002). Concordance correlation coefficients for the MVO area 
between LGE and native T1 maps, LGE and post-contrast T1 maps, and native and post-contrast T1 maps were 0.770, 0.375, 
and 0.565, respectively.
Conclusion: MVO areas were accurately delineated on native T1 maps and showed high concordance with the areas measured 
on LGE. However, post-contrast T1 maps had low detection rates and underestimated MVO areas. Collectively, native T1 mapping 
is a useful tool for detecting MVO within the infarcted myocardium.
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currently the reference standard for evaluating cardiac 
structure and function in acute coronary syndromes. Late 
gadolinium enhancement (LGE) imaging is used very widely 
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in contemporary clinical practice and cardiac imaging and 
is considered the gold standard for assessing myocardial 
viability and for differentiating ischemic and non-ischemic 
cardiomyopathy (1-3). Along with its diagnostic utility for 
acute myocardial infarction (MI), LGE imaging is also useful 
for detecting microvascular obstruction (MVO), an important 
prognostic factor of poor outcomes in patients with MI 
(4-6). MVO generally occurs following reperfusion therapy 
after prolonged myocardial ischemia and is histologically 
associated with hemorrhagic infarction. It results from 
luminal narrowing of the myocardial microvasculature 
caused by ischemic endothelial injury, and aggregates 
of fibrin, platelets, and erythrocytes then obstruct the 
narrowed microvasculature. This is known as the ‘no-reflow’ 
phenomenon (4, 7). 
On LGE images, MVO presents as a dark non-enhanced 
area within the enhanced infarcted myocardium. Patients 
with MVO on LGE images usually demonstrate adverse left 
ventricular remodeling, resulting in subsequent major 
cardiovascular events and even death (4, 7). Since LGE 
imaging is now widely employed, a gadolinium-based 
contrast agent (GBCA) is currently administered in > 80% 
of CMR procedures (3). However, caution is needed when 
using a GBCA, because the clinical significance of its tissue 
deposition remains unclear (3, 8). 
T1 mapping is a recently developed technique that 
measures the T1 relaxation time in pixels directly from 
the affected myocardium, without the need for GBCA 
administration (1, 9, 10). The T1 relaxation time of the 
myocardium depends on the disease state, due to changes in 
the tissue microenvironment (9). In MI, T1 values reportedly 
increase owing to ischemia and edema (1, 11). Nevertheless, 
a few studies have detected MVO using T1 mapping (1, 11). 
The presence of MVO is thought to decrease T1 values due 
to the extravasation of iron-containing erythrocytes and 
myocardial hemorrhage in MVO (1, 4, 11). Post-contrast 
T1 mapping is also valuable for tissue characterization, 
and measuring T1 values with extracellular GBCA provides 
information on the extracellular volume (ECV) fraction 
(12, 13). However, the injected GBCA can produce many 
confounding factors and the images are not based solely 
on T1 values (5, 13). To the best of our knowledge, this is 
the first study to focus specifically on the detection of MVO 
using both native and post-contrast T1 mapping images.
Therefore, we aimed to evaluate the usefulness of T1 
mapping for detecting MVO in reperfused acute MI and to 
compare measured MVO areas among native T1 maps, post-
contrast T1 maps, and LGE images.
MATERIALS AND METHODS
Study Population
This retrospective and observational study was approved 
by the Institutional Review Board of Gangnam Severance 
Hospital (IRB No. 3-2019-0061). The requirement for 
informed consent was waived, because all images and 
clinical data were retrospectively obtained from medical 
records.
In our institute, the database of patients who underwent 
CMR has been maintained from January 2014 and contained 
267 patients by December 2018. We retrospectively 
reviewed the database and found 78 patients with acute 
MI (ST-segment elevation MI [STEMI], n = 50; non STEMI, 
n = 28) who had undergone primary percutaneous coronary 
intervention (PCI) and then performed CMR. Among them, 
20 patients were mentioned by MVO on the LGE images from 
CMR reports. Those 20 patients (all men; mean age: 54.3 ± 
11.8 years) were included. All CMR was performed within 7 
days of admission, including LGE, native T1 mapping, and 
post-contrast T1 mapping sequences. The mean interval 
between PCI and CMR was 3.3 ± 2.2 days.
Image Acquisition
All CMR scans were performed with a 1.5-Tesla scanner 
(Magnetom Avanto, Siemens Healthineers, Erlangen, 
Germany) using a 12-element phased-array coil. Heart 
localization was performed using true fast imaging with 
steady-state precession (True FISP, Siemens Healthineers) 
under electrocardiographic gating. The protocols included 
cine CMR, native T1 mapping, LGE imaging, and post-
contrast T1 mapping. Cine images were acquired using a 
steady-state free precession sequence in the short axis 
and 2-, 3-, and 4-chamber views of the left ventricle. The 
imaging parameters were as follows: repetition time (TR), 
2.63 ms; echo time (TE), 1.1 ms; flip angle, 67°; 25 phases; 
slice thickness, 8 mm; slice gap, 2 mm; acquisition matrix, 
192 x 109; and field-of-view (FOV), 320 x 400 mm. Native 
T1 mapping was performed using a modified look-locker 
inversion recovery (MOLLI) sequence with a 5(3)3 protocol 
(14) that acquires 5 images after the first inversion pulse, 
followed by 3 RR intervals for T1 recovery, and a second 
inversion pulse after which 3 more images are acquired. 
Eight slices of T1 maps were obtained to cover the left 




740 ms; TE, 1.06 ms; flip angle, 35°; slice thickness, 8 mm; 
acquisition matrix, 192 x 124; and FOV, 320 x 400 mm (14). 
LGE imaging, with a magnitude- and phase-sensitive 
inversion recovery prepared fast gradient echo sequence, 
was conducted 10 minutes after injecting a 0.2 mmol/kg 
intravenous dose of gadoterate dimeglumine (Dotarem, 
Guerbet, Roissy, France). A bolus of contrast media was 
intravenously administered at 2 mL/s, followed by 20 mL of 
normal saline at 4 mL/s through a 20-gauge cannula in the 
antecubital vein using a power injector (Nemoto, Nemoto 
Kyorindo, Tokyo, Japan). The appropriate inversion time 
was determined before LGE imaging using a fast gradient 
echo sequence with inversion times varying from 150 to 
650 ms to null the signal from the normal myocardium. 
The LGE imaging parameters were as follows: TR, 8.8 ms; 
TE, 3.36 ms; flip angle 25°; acquisition matrix, 256 x 
166; and FOV, 276 x 340 mm. Post-contrast T1 maps were 
also acquired using the MOLLI sequence, with a 4(1)3(1)2 
scheme (14), 15 minutes after contrast agent injection. In 
addition, eight slices of T1 maps were obtained to cover 
the left ventricle fully. The imaging parameters were the 
same as those used for native T1 mapping. 
Image Analysis
Two radiologists (who had more than 10 years of 
experience in the field of cardiothoracic radiology) 
performed independent assessments, including qualitative 
and quantitative analyses, of all images. The patient’s 
identity was blinded and the patient’s orders were random. 
The two radiologists simultaneously reviewed three sets 
of images (LGE, native T1 map, and post-contrast T1 map) 
of the same patient. The radiologists were aware that 
three sets of images were from the same patient. The co-
presented LGE image was used as the reference to detect 
the infarcted myocardium and MVO on T1 maps.
Myocardial injury in ischemic conditions was defined as 
a visually identified region of hyper-enhancement in the 
left ventricular myocardium on LGE images. The MI size was 
calculated from the LGE images by the full-width at half-
maximum technique. MVO was defined separately according 
to the imaging sequence used. On LGE images, MVO was 
defined as a hypo-enhanced region within a hyper-enhanced 
infarcted myocardium. On native and post-contrast T1 maps, 
MVO was defined as a region of visually distinguishable T1 
values within the infarcted myocardium. If the MVO could be 
identified, the MVO area was measured by manually drawing 
its margin using a picture archiving and communication 
system station (Centricity 4.0, GE Healthcare, Chicago, IL, 
USA). The measured MVO areas on native and post-contrast 
T1 maps were compared with those on LGE images. The MVO 
lesions on LGE images, which were matched to the MVO 
lesions, and visualized on the native T1 and post-contrast 
T1 maps were categorized separately and the mean areas 
were calculated. In addition, the T1 value was measured by 
the MVO contour and the circles in the infarcted and remote 
myocardium on the native and post-contrast T1 maps using 
the picture archiving and communication system station. 
Three T1 values on each T1 map were compared. 
Statistical Analysis
Categorical variables are expressed as frequencies 
(percentage) and continuous variables are presented as the 
mean ± standard deviation (SD) for normally distributed 
variables and as the median (interquartile range [IQR]) for 
non-normally distributed variables. Normality assumptions 
for continuous variables were confirmed with the Shapiro-
Wilk test. 
A linear mixed model with Bonferroni correction was 
used to identify differences among the mean T1 values of 
the MVO, infarcted myocardium, and remote myocardium 
on native and post-contrast T1 maps. The median MVO 
areas on LGE images, native T1 maps, and post-contrast 
T1 maps were compared using the Friedman test. For 
post-hoc pairwise multiple comparisons, Conover’s test 
was performed. Differences were considered statistically 
significant at p < 0.05.
The concordance correlation coefficient (CCC) was used 
to evaluate the reproducibility of measuring the MVO area 
on LGE images, native T1 maps, and post-contrast T1 maps. 
Inter-observer variability with respect to measuring the 
MVO area and T1 values was assessed with the intraclass 
correlation coefficient (ICC). The agreement levels were as 
follows: poor, ICC < 0.40; fair to good, ICC = 0.40–0.75; 
and excellent, ICC = 0.76–1.00. A Bland-Altman analysis 
was conducted to investigate the agreement of the MVO 
area measurements among the imaging methods. Statistical 
analyses were performed using commercially available 
software (SPSS for Windows version 23.0, IBM Corp., 
Armonk, NY, USA; MedCalc version 11.4, MedCalc Software 
bvba, Mariakerke, Belgium).
RESULTS
The characteristics and risk factors of the 20 patients 
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are summarized in Table 1. Of the 20 patients with MVO 
detected on LGE images, MVO was visualized in 18 patients 
(90%) on native T1 maps and in 10 patients (50%) on post-
contrast T1 maps. In most cases, except false negatives, 
the MVO area was well delineated within the infarcted 
myocardium on LGE images, native T1 maps, and post-
contrast T1 maps (Fig. 1). The mean MVO areas on LGE 
images, native T1 maps, and post-contrast T1 maps were 
134.1 ± 81.2 mm2, 133.7 ± 80.4 mm2, and 117.1 ± 53.3 mm2, 
respectively. The two MVO lesions not visualized on native T1 
maps had areas measuring 30.4 mm2 and 44.4 mm2 and were 
the two smallest MVO lesions noted on LGE images. All MVO 
areas measured on post-contrast T1 maps were smaller than 
the matched MVO areas measured on LGE images (p = 0.027). 
The median (IQR) MVO areas on LGE images (n = 20), 
native T1 maps (n = 18), and post-contrast T1 maps (n = 10) 
were 128.0 (58.1–215.4) mm2, 110.5 (67.7–227.9) mm2, and 
143.0 (76.7–155.3) mm2, respectively, and were significantly 
different among them (p = 0.002) (Fig. 2). However, 
pairwise comparisons of the MVO areas between the groups 
did not show any significant differences (Table 2). The 
CCCs for the measured MVO areas between image types are 
shown in Table 2. Agreement was relatively high between 
LGE images and native T1 maps (n = 18, CCC = 0.770). 
Agreement was not good between LGE images and post-
contrast T1 maps (n = 10, CCC = 0.375). The mean area of 
the 10 MVO lesions detected on the post-contrast T1 maps 
was measured as 190.6 ± 69.7 mm2, much larger than that 
of all 20 MVO lesions on the LGE images (117.1 ± 53.3 
mm2). The Bland-Altman analysis showed that the mean 
difference in MVO area was 9.8% (n = 18, 95% confidence 
interval [CI]: -11.5–31.0%) between LGE images and native 
T1 maps, with a coefficient of repeatability (2 SDs) of 
83.8%. The mean difference in MVO area was 51.9% 
(n = 10, 95% CI: 22.2–81.6%) between LGE images and 
post-contrast T1 maps, with a coefficient of repeatability (2 
SDs) of 81.4% (Fig. 3). 
The mean T1 values of infarcted myocardium, MVO, 
and remote myocardium on native T1 maps (n = 18) were 
Fig. 1. MVO within infarcted myocardium on LGE image, native T1 map, and post-contrast T1 map. 
A. On LGE image, MVO is observed as hypo-enhanced region within hyper-enhanced infarcted myocardium. B. On native T1 map, MVO is 
distinguished as dark region within bright infarcted myocardium. C. On post-contrast T1 map, MVO is identified as bright region within dark 
infarcted myocardium. Regions of interest, in which T1 values were measured in (B) and (C), were outlined with circles in infarcted and remote 
myocardium and with contour of MVO. LGE = late gadolinium enhancement, MVO = microvascular obstruction
A B C
Table 1. Characteristics of 20 Patients with Acute Myocardial 
Infarction Who Underwent Reperfusion Treatment
Parameter Total (n = 20)
Age, years 54.3 ± 11.8
Male/female, number (%) 20 (100)/0 (0)
Body mass index, kg/m2 23.7 ± 3.6
Hypertension, number (%) 11 (55)
Hyperlipidemia, number (%) 6 (30)
Smoking history: current/ex-smoker/
  never, n (%)
11 (55)/6 (30)/3 (15)
Diabetes, n (%) 0 (0)
STEMI/NSTEMI, number (%) 19 (95)/1 (5)
Peak troponin T (median ± IQR), µg/L 42.1 ± 41.0
Time from onset of symptoms to PCI, 
  hours
3.4 ± 1.4
Time from presentation to hospital to 
  PCI, hours
1.8 ± 0.9
Time from PCI to CMR, days 3.3 ± 2.2
Mean size of myocardial infarction,
  % of left ventricular mass
27.1 ± 9.7
Data are presented as mean ± standard deviation unless otherwise 
noted. CMR = cardiovascular magnetic resonance imaging, IQR = 
interquartile range, NSTEMI = non-ST-segment elevation myocardial 
infarction, PCI = percutaneous coronary intervention, STEMI = ST-




1240.9 ± 55.8 ms, 1013.5 ± 58.5 ms, and 1062.2 ± 55.8 ms, 
respectively (Fig. 4A). On native T1 maps, the mean T1 value 
of the MVO was significantly lower than that of the infarcted 
myocardium (p < 0.001) and slightly, but not significantly, 
lower than that of the remote myocardium (p = 0.169). The 
mean T1 values of infarcted myocardium, MVO, and remote 
myocardium on post-contrast T1 maps (n = 10) were 399.1 ± 
21.3 ms, 466.7 ± 26.8 ms, and 585.2 ± 21.3 ms, respectively 
(Fig. 4B). On post-contrast T1 maps, the mean T1 value of 
the MVO was significantly higher than that of the infarcted 
myocardium (p < 0.001) and significantly lower than that of 
the remote myocardium (p < 0.001).
A complete agreement has been reached on MVO 
detection by two radiologists. The inter-observer variability 
in measuring the MVO area on LGE images, native T1 maps, 
and post-contrast T1 maps was excellent, with ICCs of 0.984, 
0.977, and 0.969, respectively. The inter-observer variability 
in measuring the T1 values on native T1 maps was excellent 
(ICC, 0.840), while that for post-contrast T1 maps was good 
(ICC, 0.696).
DISCUSSION
Herein, we compared native and post-contrast T1 
mapping with LGE imaging for delineating the MVO area in 
reperfused acute MI. There were three main findings. First, 
MVO was detected on native T1 maps in 90% of cases, but 
only detected in 50% of the cases on post-contrast T1 
maps. Post-contrast T1 maps showed tendency to detect 
large MVO lesions, rather than small ones. Second, the MVO 
area was accurately delineated and measured on native T1 
maps and the measured MVO areas were highly concordant 
with those measured on LGE images. On native T1 maps, 
the mean T1 value of the MVO was lower than that of the 
infarcted myocardium but not significantly different from 
that of the remote myocardium. Third, MVO areas measured 
on post-contrast T1 maps were underestimated relative to 
those measured on LGE images. On post-contrast T1 maps, 
the mean T1 value of the MVO was higher than that of the 
infarcted myocardium but lower than that of the remote 
myocardium. 
Many studies have compared native T1 maps with LGE or 
T2-weighted images in terms of their ability to detect MI (2, 
9-11, 15, 16). However, a few studies have compared the 
utility of native or post-contrast T1 maps with that of LGE 
images for evaluating MVO (17-19). T1 maps can be used to 
objectively measure and directly quantify the absolute T1 
relaxation time of the myocardium without contrast medium, 
thus providing an alternative imaging approach for patients 
with renal impairment. Moreover, the recent development 
and validation of a new native T1 mapping sequence 
(shortened MOLLI) allows in vivo T1 measurements and T1 
mapping of the myocardium with a higher spatial resolution 
within one breath-hold (9, 20). In this study, native T1 
maps exhibited sensitive delineation of MVO and yielded 
accurate area measurements. The mean MVO area measured 
on native T1 maps was not significantly different from that 
measured on LGE images and the reproducibility of MVO 
area measurements between these image types was high. 






















Fig. 2. MVO areas in 20 patients on LGE images, 18 patients on 
native T1 maps, and 10 patients on post-contrast T1 maps. 
Boxes, 1st–3rd quartiles; bold lines, medians; whiskers, minimum and 
maximum values.




LGE vs. Native T1 Map
(n = 18)
LGE vs. Post-Contrast T1 Map
(n = 10)
Native T1 Map vs. Post-Contrast T1 Map
(n = 10)
p value 0.69 0.69 0.43
CCC (95% CI) 0.770 (0.489–0.906) 0.375 (0.006–0.654) 0.565 (0.209–0.788)
CCC = concordance correlation coefficient, CI = confidence interval, LGE = late gadolinium enhancement, MVO = microvascular obstruction
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rate was only 50% and all detected MVO areas were 
underestimated compared to those on LGE images. Ten 
relatively larger MVO lesions measured on LGE images (mean 
area on LGE, 190.6 ± 69.7 mm2) were detectable on post-
contrast T1 maps, compared to the other 10 lesions (mean 
area on LGE, 77.6 ± 44.5 mm2). Many confounding factors 
in the post-contrast T1 measurements may have contributed 
to this underestimation, including the contrast dose, 
contrast clearance rate, scan timing, body composition, 
and hematocrit (3, 13). Because of these confounders, 
significant variations in the post-contrast T1 maps are 
inevitable. Mather et al. (18) reported that the MVO extent 
on first-pass perfusion images (median mass: 4.7 g) was 
greater than those on early GBCA enhancement images 
(median mass: 2.3 g, p < 0.05) and LGE images (median 





















































Mean of LGE and post T1 map
Fig. 3. Bland-Altman plots showing comparison of MVO areas between image types. 
A. Mean difference in MVO area between LGE images and native T1 maps was 9.8% (n = 18, 95% CI: -11.5–31.0%), and coefficient of 
repeatability (2 SDs) was 83.8%. B. Mean difference in MVO size between LGE images and post-contrast T1 map images was 51.9% (n = 10, 95% 

















































Fig. 4. T1 values of infarcted myocardium, MVO, and remote myocardium on native T1 maps (n = 18) and post-contrast T1 maps 
(n = 10). 
A. On native T1 maps, mean T1 value of MVO was lower than that of infarcted myocardium, but was not statistically different from that of remote 
myocardium. B. On post-contrast T1 maps, mean T1 value of MVO was significantly higher than that of infarcted myocardium, but significantly 






treated with primary PCI. Several studies, including that 
by Mather et al. (18), showed that GBCA extravasated into 
the interstitium and passively diffused into the MVO area 
(21, 22). Therefore, the MVO area decreased over time 
following GBCA injection. The LGE images and post-contrast 
T1 maps in the present study were obtained 10 minutes and 
15 minutes after GBCA injection, respectively. Thus, based 
on the abovementioned previous studies, post-contrast 
T1 maps may underestimate the MVO area relative to LGE 
images because there are five more minutes for GBCA to 
diffuse into the MVO area. Although the post-contrast T1 
mapping did not demonstrate the preferred output in this 
study, it provides important information on the ECV fraction 
or myocardial ECV, which is altered by infiltrative myocardial 
disease, edema, fibrosis, or myocardial remodeling (23).
In this study, the mean native T1 relaxation time of MVO 
was significantly lower than that of infarcted myocardium 
without MVO, and this finding is similar to the results 
of previous studies (1, 5, 9, 10). Prior studies using 
histological assessments revealed that the segments of 
acute MI demonstrate increased tissue water content and 
that such segments show increased T1 values on native 
T1 maps (9, 24). Edema is a typical feature of ischemia-
reperfusion injury and represents the inflammation state 
of the infarcted myocardial tissues (9, 25). Myocardial 
hemorrhage is another component of reperfusion injury 
that results from the extravasation of red blood cells 
through damaged endothelial walls during reperfusion (1, 
9, 10, 22). Hemorrhage is frequently visible within the 
infarct core and is closely related to MVO. Hemoglobin 
in the extravasated red blood cells undergoes oxidative 
denaturation and produces paramagnetic substances, 
including deoxyhemoglobin, methemoglobin, ferritin, and 
hemosiderin, which result in shortening of the native T1 
values of MVOs (10, 25-27). Moreover, the reduced water 
content in the MVO contributes to the shortening of the 
native T1 values compared to the infarcted tissues without 
MVO (9, 28, 29).
In previous studies, the mean native T1 value of the 
MVO was higher than that of the remote myocardium 
(1, 5, 9, 10). However, in our study, the mean native T1 
value of the MVO was lower, though not significantly, 
than that of the remote myocardium. Biesbroek et al. (5) 
revealed that patients with more extensive myocardial 
damage demonstrate higher native T1 values at the remote 
myocardium after treatment with primary PCI. In that study, 
the median infarct size measured on LGE images was 16% 
(IQR: 8–26%) of the left ventricular mass and 55% of the 
patients had MVO (5). These changes might be associated 
with adverse cardiac remodeling after acute MI, and the 
severity of myocardial damage likely determined the tissue 
response of the remote myocardium. The mean infarct size 
measured on LGE images in our study was 27.1 ± 9.7% of 
the left ventricular mass and the median infarct size was 
24% (18–36%) of the left ventricular mass, which is larger 
than that in the previous study (5). Furthermore, MVO was 
detected in all 20 patients in this study on LGE images. 
Hence, extensive myocardial damage may explain why the 
mean native T1 value of the remote myocardium was higher 
than that of MVO in our study. 
On post-contrast T1 maps, the mean T1 value of the 
MVO was significantly higher than that of the infarcted 
myocardium, but significantly lower than that of the 
remote myocardium. This is because the GBCA stayed in the 
infarcted tissues, causing shortening of the T1 relaxation 
time. Similar to native T1 maps, myocardial hemorrhage may 
have contributed to the lower T1 value in the MVO than in 
the remote myocardium for post-contrast T1 maps. 
There are several limitations to this study. First, MVO 
detection and area measurements were assessed visually. 
Many artifacts, including partial volume effects, cardiac and 
respiratory motion artifacts, B0-field inhomogeneity, and 
edge artifacts may have interfered with accurate assessment 
(13). Second, LGE images were used as reference to detect 
the infarcted myocardium and MVO on T1 maps. To evaluate 
the diagnostic performance of T1 maps for detecting and 
delineating MVO compared to that of LGE images, the 
operators should be blinded to LGE images when they were 
analyzing T1 maps. Third, histopathological corroboration 
of the infarcted myocardium, MVO, and remote myocardium 
was not performed. Ideally, the tissues that correspond 
to the measured areas on images should be observed in 
order to help identify mechanisms that may have led to 
T1 value changes. Fourth, T2*-weighted CMR was not 
performed to detect myocardial hemorrhage. Finally, this 
was a retrospective, single-center study with a small sample 
size, and thus the findings may not be generalizable to all 
patients. Therefore, studies with larger sample sizes are 
necessary for further validation.
In conclusion herein, using native T1 maps, MVO areas 
were accurately delineated and these areas showed high 
concordance with the areas measured on LGE images. 
However, post-contrast T1 maps had low MVO detection 
rates and produced underestimated MVO areas. Collectively, 
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our findings suggest that native T1 mapping is a useful 
tool for detecting MVO within an infarcted myocardium that 
clearly shows a low T1 value.
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